An unexpected parasitic cause of hypereosinophilia: Fascioliasis

Turkish Journal of Pediatrics

Volumn 53, Issue 1, 2011, Pages 111-113

  Gökçe, Müge ^a   Şahiner, Ümit ^a   Ünal, Şule ^a   Parlakay, Aslinur ^a   Öncel, Ibrahim ^a   Saçkesen, Cansin ^a   Kara, Ateş ^a   Gümrük, Fatma ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Fasciola hepatica; Hypereosinophilia; Hyperleukocytosis

Indexed keywords

STEROID; TRICLABENDAZOLE; ANTHELMINTIC AGENT; BENZIMIDAZOLE DERIVATIVE;

ABDOMINAL PAIN; ARTICLE; CASE REPORT; CHILD; DRUG WITHDRAWAL; ECHOGRAPHY; EOSINOPHILIA; FASCIOLA HEPATICA; FASCIOLIASIS; FOLLOW UP; HEPATOMEGALY; HOSPITAL ADMISSION; HUMAN; HYPEREOSINOPHILIA; LEUKOCYTE COUNT; LEUKOCYTOSIS; LOW DRUG DOSE; MALE; OUTPATIENT DEPARTMENT; PRESCHOOL CHILD; SEROLOGY; SINGLE DRUG DOSE; TURKEY (REPUBLIC); FECES; PARASITOLOGY;

ANTHELMINTICS; BENZIMIDAZOLES; CHILD; EOSINOPHILIA; FASCIOLIASIS; FECES; HUMANS; LEUKOCYTE COUNT; MALE;

EID: 79958756190     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Wagelie-Steffen A, Aceves SS. Eosinophilic disorders in children. Curr Allergy Asthma Rep 2006; 6: 475-482.
2. Demirci M, Korkmaz M, Sakru N, Kaya S, Kuman A. Diagnostic importance of serological methods and eosinophilia in tissue parasites. J Health Popul Nutr 2002; 20: 352-355.
3. Demirci M, Korkmaz M, Kaya S, Kuman A. Fascioliasis in eosinophilic patients in the Isparta region of Turkey. Infection 2003; 31: 15-18.
4. Cosme A, Ojeda E, Poch M, Bujanda L, Castiella A, Fernandez J. Sonographic findings of hepatic lesions in human fascioliasis. J Clin Ultrasound 2003; 31: 358-363.
5. Lampinen M, Carlson M, Hakansson LD, Venge P. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 2004; 59: 793-805.
6. Warren DJ, Moore MA. Synergism among interleukin 1, interleukin 3 and interleukin 5 in the production of eosinophils from primitive hematopoietic stem cells. J Immunol 1988; 140: 94-98.
7. Risk Control of Foodborne Trematode Infection. WHO Technical Series No 849 Geneva: WHO; 1995: 157.
8. Marcos L, Maco V, Samalvides F, Terashima A, Espinoza JR, Gotuzzo E. Risk factors of Fasciola hepatica infection in children: a case-control study. Trans R Soc Trop Med Hyg 2006; 100: 158-166.
9. El-Shabrawi M, el-Karaksy H, Okasha S, el-Hennawy A. Human fascioliasis: clinical features and diagnostic difficulties in Egyptian children. J Trop Pediatr 1997; 43: 162-166.
10. Zhou L, Luo L, You C, et al. Multiple brain hemorrhages and hematomas associated with ectopic fascioliasis in brain and eye. Surg Neurol 2008; 69: 516-521.
11. Makay O, Gurcu B, Caliskan C, Nart D, Tuncyürek M, Korkut M. Ectopic fascioliasis mimicking a colon tumor. World J Gastroenterol 2007; 13: 2633-2635.
12. Heukelbach J, Poggensee G, Winter B, Wilcke T, Kerr-Pontes LR. Leukocytosis and blood eosinophilia in a polyparasitised population in North-eastern Brazil. Trans R Soc Trop Med Hyg 2006; 100: 32-40.
13. El-Karaksy H, Hassanein B, Okasha S, Behairy B, Gadallah I. Human fascioliasis in Egyptian children: succesful tretament with triclabendazole. J Tropic Pediatr 1999; 45: 135-138.
14. Doǧan S, Beyazit Y, Altintaş ND, et al. Systemic toxocariasis presenting with leukemoid reaction and hypereosinophilia. Am J Hematol 2005; 79: 171.
15. Millan JC, Mull R, Freise S, Richter J. The efficacy and tolerability of triclabendazole in Cuban patients with latent and chronic Fasciola hepatica infection. Am J Trop Med Hyg 2000; 63: 264-269.